proteon manager 3.1.0 Search Results


enterococcus faecalis schleifer and kilpper-balz  (ATCC)
99
ATCC enterococcus faecalis schleifer and kilpper-balz
Enterococcus Faecalis Schleifer And Kilpper Balz, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/enterococcus faecalis schleifer and kilpper-balz/product/ATCC
Average 99 stars, based on 1 article reviews
enterococcus faecalis schleifer and kilpper-balz - by Bioz Stars, 2026-04
99/100 stars
  Buy from Supplier
proteon manager 3 1 0 software  (Bio-Rad)
96
Bio-Rad proteon manager 3 1 0 software
Proteon Manager 3 1 0 Software, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/proteon manager 3 1 0 software/product/Bio-Rad
Average 96 stars, based on 1 article reviews
proteon manager 3 1 0 software - by Bioz Stars, 2026-04
96/100 stars
  Buy from Supplier
proteon manager version 3.1.0.6  (Bio-Rad)
90
Bio-Rad proteon manager version 3.1.0.6
Proteon Manager Version 3.1.0.6, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/proteon manager version 3.1.0.6/product/Bio-Rad
Average 90 stars, based on 1 article reviews
proteon manager version 3.1.0.6 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
computer code data collection biorad proteon manager software  (Bio-Rad)
96
Bio-Rad computer code data collection biorad proteon manager software
Computer Code Data Collection Biorad Proteon Manager Software, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/computer code data collection biorad proteon manager software/product/Bio-Rad
Average 96 stars, based on 1 article reviews
computer code data collection biorad proteon manager software - by Bioz Stars, 2026-04
96/100 stars
  Buy from Supplier
proteon manager version 3 1 0 6  (Bio-Rad)
93
Bio-Rad proteon manager version 3 1 0 6
(A) ELISA demonstrating the binding specificity of 14-25-9 mAb with plate-bound recombinant MBP- and His-tagged hPCNA. His-DJ1 (negative control) and mIgG1 (isotype control). (B) Western blot image demonstrating specific binding of 14-25-9 with His-hPCNA (30kDa) and MBP-hPCNA (71.5kDa) and no binding with His-DJ1. (C) <t>ProteOn</t> array showing the affinity of 14-25-9 at a concentration range of 0–100nM to His-hPCNA. Concentrations represented with lines are, 0nM (Violet, base-line), 6.25nM (Yellow), 25nM (Green), 50nM (Blue), and 100nM (Red). Analysis: bivalent binding model. (D-E) Western blot images showing recognition of endogenous PCNA. Data are representative of three independent experiments. (F) ELISA demonstrating inhibition of NKp44-Ig binding with plate-bound MBP-hPCNA by titrated 14-25-9 and PC10. Percentages of NKp44-Ig binding, were calculated against no-antibody incubation value. Data represents mean±SD of two independent experiments in n=3 biological replicates for each dose. One-way ANOVA was performed among the groups; comparison was done between PC10 and 14-25-9 groups. * p<0.05, **p<0.01, ***p<0.001.
Proteon Manager Version 3 1 0 6, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/proteon manager version 3 1 0 6/product/Bio-Rad
Average 93 stars, based on 1 article reviews
proteon manager version 3 1 0 6 - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier
proteus mirabilis hauser  (ATCC)
96
ATCC proteus mirabilis hauser
(A) ELISA demonstrating the binding specificity of 14-25-9 mAb with plate-bound recombinant MBP- and His-tagged hPCNA. His-DJ1 (negative control) and mIgG1 (isotype control). (B) Western blot image demonstrating specific binding of 14-25-9 with His-hPCNA (30kDa) and MBP-hPCNA (71.5kDa) and no binding with His-DJ1. (C) <t>ProteOn</t> array showing the affinity of 14-25-9 at a concentration range of 0–100nM to His-hPCNA. Concentrations represented with lines are, 0nM (Violet, base-line), 6.25nM (Yellow), 25nM (Green), 50nM (Blue), and 100nM (Red). Analysis: bivalent binding model. (D-E) Western blot images showing recognition of endogenous PCNA. Data are representative of three independent experiments. (F) ELISA demonstrating inhibition of NKp44-Ig binding with plate-bound MBP-hPCNA by titrated 14-25-9 and PC10. Percentages of NKp44-Ig binding, were calculated against no-antibody incubation value. Data represents mean±SD of two independent experiments in n=3 biological replicates for each dose. One-way ANOVA was performed among the groups; comparison was done between PC10 and 14-25-9 groups. * p<0.05, **p<0.01, ***p<0.001.
Proteus Mirabilis Hauser, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/proteus mirabilis hauser/product/ATCC
Average 96 stars, based on 1 article reviews
proteus mirabilis hauser - by Bioz Stars, 2026-04
96/100 stars
  Buy from Supplier
candida albicans berkhout  (ATCC)
99
ATCC candida albicans berkhout
(A) ELISA demonstrating the binding specificity of 14-25-9 mAb with plate-bound recombinant MBP- and His-tagged hPCNA. His-DJ1 (negative control) and mIgG1 (isotype control). (B) Western blot image demonstrating specific binding of 14-25-9 with His-hPCNA (30kDa) and MBP-hPCNA (71.5kDa) and no binding with His-DJ1. (C) <t>ProteOn</t> array showing the affinity of 14-25-9 at a concentration range of 0–100nM to His-hPCNA. Concentrations represented with lines are, 0nM (Violet, base-line), 6.25nM (Yellow), 25nM (Green), 50nM (Blue), and 100nM (Red). Analysis: bivalent binding model. (D-E) Western blot images showing recognition of endogenous PCNA. Data are representative of three independent experiments. (F) ELISA demonstrating inhibition of NKp44-Ig binding with plate-bound MBP-hPCNA by titrated 14-25-9 and PC10. Percentages of NKp44-Ig binding, were calculated against no-antibody incubation value. Data represents mean±SD of two independent experiments in n=3 biological replicates for each dose. One-way ANOVA was performed among the groups; comparison was done between PC10 and 14-25-9 groups. * p<0.05, **p<0.01, ***p<0.001.
Candida Albicans Berkhout, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/candida albicans berkhout/product/ATCC
Average 99 stars, based on 1 article reviews
candida albicans berkhout - by Bioz Stars, 2026-04
99/100 stars
  Buy from Supplier
escherichia coli castellani and chalmers  (ATCC)
99
ATCC escherichia coli castellani and chalmers
(A) ELISA demonstrating the binding specificity of 14-25-9 mAb with plate-bound recombinant MBP- and His-tagged hPCNA. His-DJ1 (negative control) and mIgG1 (isotype control). (B) Western blot image demonstrating specific binding of 14-25-9 with His-hPCNA (30kDa) and MBP-hPCNA (71.5kDa) and no binding with His-DJ1. (C) <t>ProteOn</t> array showing the affinity of 14-25-9 at a concentration range of 0–100nM to His-hPCNA. Concentrations represented with lines are, 0nM (Violet, base-line), 6.25nM (Yellow), 25nM (Green), 50nM (Blue), and 100nM (Red). Analysis: bivalent binding model. (D-E) Western blot images showing recognition of endogenous PCNA. Data are representative of three independent experiments. (F) ELISA demonstrating inhibition of NKp44-Ig binding with plate-bound MBP-hPCNA by titrated 14-25-9 and PC10. Percentages of NKp44-Ig binding, were calculated against no-antibody incubation value. Data represents mean±SD of two independent experiments in n=3 biological replicates for each dose. One-way ANOVA was performed among the groups; comparison was done between PC10 and 14-25-9 groups. * p<0.05, **p<0.01, ***p<0.001.
Escherichia Coli Castellani And Chalmers, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/escherichia coli castellani and chalmers/product/ATCC
Average 99 stars, based on 1 article reviews
escherichia coli castellani and chalmers - by Bioz Stars, 2026-04
99/100 stars
  Buy from Supplier
gamunex2 immune globulin intravenous (human), 10% caprylate/ chromatography purified  (Talecris Biotherapeutics)
90
Talecris Biotherapeutics gamunex2 immune globulin intravenous (human), 10% caprylate/ chromatography purified
(A) ELISA demonstrating the binding specificity of 14-25-9 mAb with plate-bound recombinant MBP- and His-tagged hPCNA. His-DJ1 (negative control) and mIgG1 (isotype control). (B) Western blot image demonstrating specific binding of 14-25-9 with His-hPCNA (30kDa) and MBP-hPCNA (71.5kDa) and no binding with His-DJ1. (C) <t>ProteOn</t> array showing the affinity of 14-25-9 at a concentration range of 0–100nM to His-hPCNA. Concentrations represented with lines are, 0nM (Violet, base-line), 6.25nM (Yellow), 25nM (Green), 50nM (Blue), and 100nM (Red). Analysis: bivalent binding model. (D-E) Western blot images showing recognition of endogenous PCNA. Data are representative of three independent experiments. (F) ELISA demonstrating inhibition of NKp44-Ig binding with plate-bound MBP-hPCNA by titrated 14-25-9 and PC10. Percentages of NKp44-Ig binding, were calculated against no-antibody incubation value. Data represents mean±SD of two independent experiments in n=3 biological replicates for each dose. One-way ANOVA was performed among the groups; comparison was done between PC10 and 14-25-9 groups. * p<0.05, **p<0.01, ***p<0.001.
Gamunex2 Immune Globulin Intravenous (Human), 10% Caprylate/ Chromatography Purified, supplied by Talecris Biotherapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gamunex2 immune globulin intravenous (human), 10% caprylate/ chromatography purified/product/Talecris Biotherapeutics
Average 90 stars, based on 1 article reviews
gamunex2 immune globulin intravenous (human), 10% caprylate/ chromatography purified - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
recombinant dna pmscv cre puro ires gfp addgene plasmid  (Addgene inc)
93
Addgene inc recombinant dna pmscv cre puro ires gfp addgene plasmid
(A) ELISA demonstrating the binding specificity of 14-25-9 mAb with plate-bound recombinant MBP- and His-tagged hPCNA. His-DJ1 (negative control) and mIgG1 (isotype control). (B) Western blot image demonstrating specific binding of 14-25-9 with His-hPCNA (30kDa) and MBP-hPCNA (71.5kDa) and no binding with His-DJ1. (C) <t>ProteOn</t> array showing the affinity of 14-25-9 at a concentration range of 0–100nM to His-hPCNA. Concentrations represented with lines are, 0nM (Violet, base-line), 6.25nM (Yellow), 25nM (Green), 50nM (Blue), and 100nM (Red). Analysis: bivalent binding model. (D-E) Western blot images showing recognition of endogenous PCNA. Data are representative of three independent experiments. (F) ELISA demonstrating inhibition of NKp44-Ig binding with plate-bound MBP-hPCNA by titrated 14-25-9 and PC10. Percentages of NKp44-Ig binding, were calculated against no-antibody incubation value. Data represents mean±SD of two independent experiments in n=3 biological replicates for each dose. One-way ANOVA was performed among the groups; comparison was done between PC10 and 14-25-9 groups. * p<0.05, **p<0.01, ***p<0.001.
Recombinant Dna Pmscv Cre Puro Ires Gfp Addgene Plasmid, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant dna pmscv cre puro ires gfp addgene plasmid/product/Addgene inc
Average 93 stars, based on 1 article reviews
recombinant dna pmscv cre puro ires gfp addgene plasmid - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier
auy922  (Rexin Pharmaceuticals)
90
Rexin Pharmaceuticals auy922
(A) ELISA demonstrating the binding specificity of 14-25-9 mAb with plate-bound recombinant MBP- and His-tagged hPCNA. His-DJ1 (negative control) and mIgG1 (isotype control). (B) Western blot image demonstrating specific binding of 14-25-9 with His-hPCNA (30kDa) and MBP-hPCNA (71.5kDa) and no binding with His-DJ1. (C) <t>ProteOn</t> array showing the affinity of 14-25-9 at a concentration range of 0–100nM to His-hPCNA. Concentrations represented with lines are, 0nM (Violet, base-line), 6.25nM (Yellow), 25nM (Green), 50nM (Blue), and 100nM (Red). Analysis: bivalent binding model. (D-E) Western blot images showing recognition of endogenous PCNA. Data are representative of three independent experiments. (F) ELISA demonstrating inhibition of NKp44-Ig binding with plate-bound MBP-hPCNA by titrated 14-25-9 and PC10. Percentages of NKp44-Ig binding, were calculated against no-antibody incubation value. Data represents mean±SD of two independent experiments in n=3 biological replicates for each dose. One-way ANOVA was performed among the groups; comparison was done between PC10 and 14-25-9 groups. * p<0.05, **p<0.01, ***p<0.001.
Auy922, supplied by Rexin Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/auy922/product/Rexin Pharmaceuticals
Average 90 stars, based on 1 article reviews
auy922 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
ras/rap gtpase-activating protein  (SynGap Research Fund Inc)
90
SynGap Research Fund Inc ras/rap gtpase-activating protein
(A) ELISA demonstrating the binding specificity of 14-25-9 mAb with plate-bound recombinant MBP- and His-tagged hPCNA. His-DJ1 (negative control) and mIgG1 (isotype control). (B) Western blot image demonstrating specific binding of 14-25-9 with His-hPCNA (30kDa) and MBP-hPCNA (71.5kDa) and no binding with His-DJ1. (C) <t>ProteOn</t> array showing the affinity of 14-25-9 at a concentration range of 0–100nM to His-hPCNA. Concentrations represented with lines are, 0nM (Violet, base-line), 6.25nM (Yellow), 25nM (Green), 50nM (Blue), and 100nM (Red). Analysis: bivalent binding model. (D-E) Western blot images showing recognition of endogenous PCNA. Data are representative of three independent experiments. (F) ELISA demonstrating inhibition of NKp44-Ig binding with plate-bound MBP-hPCNA by titrated 14-25-9 and PC10. Percentages of NKp44-Ig binding, were calculated against no-antibody incubation value. Data represents mean±SD of two independent experiments in n=3 biological replicates for each dose. One-way ANOVA was performed among the groups; comparison was done between PC10 and 14-25-9 groups. * p<0.05, **p<0.01, ***p<0.001.
Ras/Rap Gtpase Activating Protein, supplied by SynGap Research Fund Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ras/rap gtpase-activating protein/product/SynGap Research Fund Inc
Average 90 stars, based on 1 article reviews
ras/rap gtpase-activating protein - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

Image Search Results


(A) ELISA demonstrating the binding specificity of 14-25-9 mAb with plate-bound recombinant MBP- and His-tagged hPCNA. His-DJ1 (negative control) and mIgG1 (isotype control). (B) Western blot image demonstrating specific binding of 14-25-9 with His-hPCNA (30kDa) and MBP-hPCNA (71.5kDa) and no binding with His-DJ1. (C) ProteOn array showing the affinity of 14-25-9 at a concentration range of 0–100nM to His-hPCNA. Concentrations represented with lines are, 0nM (Violet, base-line), 6.25nM (Yellow), 25nM (Green), 50nM (Blue), and 100nM (Red). Analysis: bivalent binding model. (D-E) Western blot images showing recognition of endogenous PCNA. Data are representative of three independent experiments. (F) ELISA demonstrating inhibition of NKp44-Ig binding with plate-bound MBP-hPCNA by titrated 14-25-9 and PC10. Percentages of NKp44-Ig binding, were calculated against no-antibody incubation value. Data represents mean±SD of two independent experiments in n=3 biological replicates for each dose. One-way ANOVA was performed among the groups; comparison was done between PC10 and 14-25-9 groups. * p<0.05, **p<0.01, ***p<0.001.

Journal: Cancer immunology research

Article Title: Inhibition of the NKp44-PCNA Immune Checkpoint Using a mAb to PCNA

doi: 10.1158/2326-6066.CIR-19-0023

Figure Lengend Snippet: (A) ELISA demonstrating the binding specificity of 14-25-9 mAb with plate-bound recombinant MBP- and His-tagged hPCNA. His-DJ1 (negative control) and mIgG1 (isotype control). (B) Western blot image demonstrating specific binding of 14-25-9 with His-hPCNA (30kDa) and MBP-hPCNA (71.5kDa) and no binding with His-DJ1. (C) ProteOn array showing the affinity of 14-25-9 at a concentration range of 0–100nM to His-hPCNA. Concentrations represented with lines are, 0nM (Violet, base-line), 6.25nM (Yellow), 25nM (Green), 50nM (Blue), and 100nM (Red). Analysis: bivalent binding model. (D-E) Western blot images showing recognition of endogenous PCNA. Data are representative of three independent experiments. (F) ELISA demonstrating inhibition of NKp44-Ig binding with plate-bound MBP-hPCNA by titrated 14-25-9 and PC10. Percentages of NKp44-Ig binding, were calculated against no-antibody incubation value. Data represents mean±SD of two independent experiments in n=3 biological replicates for each dose. One-way ANOVA was performed among the groups; comparison was done between PC10 and 14-25-9 groups. * p<0.05, **p<0.01, ***p<0.001.

Article Snippet: For the assay, a HTG sensor chip (#1765031) and ProteOn Manager Version 3.1.0.6 (Bio-Rad Laboratories) were employed.

Techniques: Enzyme-linked Immunosorbent Assay, Binding Assay, Recombinant, Negative Control, Control, Western Blot, Concentration Assay, Inhibition, Incubation, Comparison